Discontinuation of PAR-11-343 "NeuroNEXT Clinical Trials (U01)"

Notice Number: NOT-NS-13-034

Update: The following update relating to this announcement has been issued:

Key Dates
Release Date: July 3, 2013

Related Announcements
PAR-11-343

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

This Notice informs potential applicants that NINDS will discontinue PAR-11-343 "NeuroNEXT Clinical Trials (U01). Applications will not be accepted by NINDS for this Funding Opportunity Announcement after August 3, 2013.

Inquiries

Please direct all inquiries to:

D. Elizabeth McNeil, MD, MSc
National Institute of Neurological Disorders and Stroke
Office of Clinical Trials
6001 Executive Blvd, Room 2114
Bethesda, MD 20892
Telephone: (301) 496-4135
Email: mcneilde@ninds.nih.gov

 


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.